Obstetrics/Gynecology · Newark, DE
NPI
1255338844
Since 2005
Specialty
Obstetrics/Gynecology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4745 Ogletown Stanton Rd, Ste 105
Newark, DE, 19713
Phone (302) 368-3257
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,147
74 services
Medicare patients, 2024
53
Average age 70
Drug cost, 2024
$34K
120 prescriptions
Company payments, 2025
$162
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Fink was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 28 times for 28 patients. In total David M Fink billed 74 services in 12 codes, and Medicare paid $3,147.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Facility | 28 | 28 | $26.64 | $746 |
By year: 2022 $2,827 for 75 services; 2023 $2,467 for 76 services; 2024 $3,147 for 74 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Fink prescribed most often to Medicare patients was Estradiol, with 26 prescriptions and refills. In total David M Fink wrote 120 Medicare prescriptions that cost $34K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 26 | 59 | Under 11 | $1,606 |
| Norethindrone Acetate Generic | 25 | 40 | Under 11 | $2,026 |
Brand drugs: - claims; generic drugs: 103 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Fink $162 ($162 in general payments such as food, travel and fees) from 7 companies. The largest payer was Exeltis, USA Inc. with $41.23.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.